Barbara Burtness
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC (NCT05317000) | Barbara Burtness | 2023-03-23 |
Track Barbara Burtness automatically
Every clearance here is in the API, with alerts when new ones post.